Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Dynavox Group AB ( (SE:DYVOX) ) has shared an announcement.
Dynavox Group reported record fourth-quarter and full-year 2025 results, with Q4 revenue up 16% to SEK 677 million and full-year revenue up 25% to SEK 2,467 million, driven by strong demand across markets and product categories despite negative currency effects and non-recurring costs. Operating margins remained robust at 15.2% in Q4 and 10.3% for the year, as the company absorbed roughly SEK 100 million in one-off expenses tied to consolidating product development in Stockholm, implementing a new ERP system in North America, and relocating its North American operations to a new facility in Pittsburgh. Cash flow after continuous investments was positive in Q4 but slightly negative for the full year, and the board proposed a dividend of SEK 0.5 per share. Strategically, Dynavox strengthened its European footprint by agreeing to acquire its Italian reseller SR Labs Healthcare, which is expected to close in the first half of 2026, while benefiting from limited exposure to U.S. import tariffs due to its products’ medical classification. Management signals confidence in continued scalable growth in a severely underpenetrated market, underpinned by normalized working capital, ongoing ERP rollouts at a lower cost, and sustained demand for its assistive communication solutions.
The most recent analyst rating on (SE:DYVOX) stock is a Hold with a SEK125.00 price target. To see the full list of analyst forecasts on Dynavox Group AB stock, see the SE:DYVOX Stock Forecast page.
More about Dynavox Group AB
Dynavox Group AB is a Stockholm-based provider of assistive communication solutions, focusing on touch-controlled devices for younger users with autism and eye-gaze controlled systems for individuals with more complex communication needs. The company operates across multiple markets, including North America and Europe, and targets a structurally underpenetrated segment of medically certified assistive devices, positioning itself as a specialized player in augmentative and alternative communication technologies.
Average Trading Volume: 292,301
Technical Sentiment Signal: Buy
Current Market Cap: SEK9.1B
For detailed information about DYVOX stock, go to TipRanks’ Stock Analysis page.